Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

PN 27.1 compassionate use trial broadened

June 14, 1996

ZK-138723: Schering AG's aromatase inhibitor

June 14, 1996

RPR's Taxotere available in the U.S.

June 14, 1996

Navelbine on Canadian market

June 14, 1996

ISIS-5132/CGP-69846A efficacy reported in Nature Medicine

June 7, 1996

Indena claims colchicine derivatives

June 7, 1996

Manufacturing agreement for Neoprobe's RIGS/ACT activated cell therapy

June 7, 1996

Melanogenesis inhibitor revealed

June 7, 1996

Ongoing evaluation of Pharmacia & Upjohn's new water-soluble camptothecin derivative

June 7, 1996

New 5-FU molecular combination merits further study

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...